Synovus Financial Corp Heska Corp Transaction History

Synovus Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$72.92 - $99.73 $11,375 - $15,557	156 Added 3.0%	5,355 $392,000
Q2 2022 Aug 10, 2022	BUY	$84.23 - $147.57 $11,623 - $20,364	138 Added 2.73%	5,199 $493,000
Q1 2022 May 12, 2022	BUY	$122.89 - $171.74 $136,162 - $190,287	1,108 Added 28.03%	5,061 $703,000
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $165,672 - $282,258	1,062 Added 36.73%	3,953 $716,000
Q3 2021 Nov 08, 2021	BUY	$228.69 - $274.2 $68,378 - $81,985	299 Added 11.54%	2,891 $755,000
Q2 2021 Aug 11, 2021	BUY	$169.89 - $231.37 $74,581 - $101,571	439 Added 20.39%	2,592 $593,000
Q1 2021 May 11, 2021	BUY	$143.93 - $207.3 $309,881 - $446,316	2,153 New	2,153 $369,000

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.